Structural Basis for the Functional Roles of Critical Residues in Human Cytochrome P450 Aromatase

被引:67
|
作者
Lo, Jessica [1 ]
Di Nardo, Giovanna [2 ]
Griswold, Jennifer [3 ]
Egbuta, Chinaza [1 ]
Jiang, Wenhua [1 ]
Gilardi, Gianfranco [2 ]
Ghosh, Debashis [1 ]
机构
[1] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA
[2] Univ Turin, Dept Life Sci & Syst Biol, I-10123 Turin, Italy
[3] Hauptman Woodward Med Res Inst, Dept Biol Struct, Buffalo, NY 14203 USA
基金
美国国家卫生研究院;
关键词
SITE-DIRECTED MUTAGENESIS; HUMAN PLACENTAL AROMATASE; ESCHERICHIA-COLI; MOLECULAR-BASIS; ACTIVE-SITE; EXPRESSION; INHIBITION; AROMATIZATION; SPECIFICITY; SYSTEM;
D O I
10.1021/bi400669h
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytochrome P450 aromatase (CYP19A1) is the only enzyme known to catalyze the biosynthesis of estrogens from androgens. The crystal structure of human placental aromatase (pArom) has paved the way toward understanding the structure function relationships of this remarkable enzyme. Using an amino,. terminus-truncated recombinant human aromatase (rArom) construct, we investigate the roles of key amino acids in the active site, at the intermolecular interface, inside the access channel, and at the lipid protein boundary for their roles in enzyme function and higher-order organization. Replacing the active site residue D309 with an N yields an inactive enzyme, consistent with its proposed involvement in aromatization. Mutation of R192 at the lipid interface, pivotal to the proton relay network in the access channel, results in the loss of enzyme activity. In addition to the distal catalytic residues, we show that mutation of K440 and Y361 of the heme-proximal region critically interferes with substrate binding, enzyme activity, and heme stability. The D-E loop deletion mutant Del7 that disrupts the intermolecular interaction significantly reduces enzyme activity. However, the less drastic Del4 and point mutants E181A and E181K do not. Furthermore, native gel electrophoresis, size-exclusion chromatography, and analytical ultracentrifugation are used to show that mutations in the intermolecular interface alter the quaternary organization of the enzyme in solution. As a validation for interpretation of the mutational results in the context of the innate molecule, we determine the crystal structure of rArom to show that the active site, tertiary, and quaternary structures are identical to those of pArom.
引用
收藏
页码:5821 / 5829
页数:9
相关论文
共 50 条
  • [41] Evolutionary comparisons predict that dimerization of human cytochrome P450 aromatase increases its enzymatic activity and efficiency
    Martin, Lisandra L.
    Holien, Jessica K.
    Mizrachi, Dario
    Corbin, C. Jo
    Conley, Alan J.
    Parker, Michael W.
    Rodgers, Raymond J.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2015, 154 : 294 - 301
  • [42] Phylogenetic and functional analyses of the cytochrome P450 family 4
    Kirischian, Nina L.
    Wilson, Joanna Y.
    MOLECULAR PHYLOGENETICS AND EVOLUTION, 2012, 62 (01) : 458 - 471
  • [43] The molecular basis for the inhibition of human cytochrome P450 1A2 by oroxylin and wogonin
    Yong-Xian Shao
    Peng Zhao
    Zhe Li
    Ming Liu
    Peiqing Liu
    Min Huang
    Hai-Bin Luo
    European Biophysics Journal, 2012, 41 : 297 - 306
  • [44] Insights into Molecular Basis of Cytochrome P450 Inhibitory Promiscuity of Compounds
    Cheng, Feixiong
    Yu, Yue
    Zhou, Yadi
    Shen, Zhonghua
    Xiao, Wen
    Liu, Guixia
    Li, Weihua
    Lee, Philip W.
    Tang, Yun
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2011, 51 (10) : 2482 - 2495
  • [45] Structural Basis of Single-Nucleotide Polymorphisms in Cytochrome P450 2C9
    Maekawa, Keiko
    Adachi, Motoyasu
    Matsuzawa, Yumiko
    Zhang, Qinghai
    Kuroki, Ryota
    Saito, Yoshiro
    Shah, Manish B.
    BIOCHEMISTRY, 2017, 56 (41) : 5476 - 5480
  • [46] Structural and functional insights into polymorphic enzymes of cytochrome P450 2C8
    Jiang, Hualin
    Zhong, Fangfang
    Sun, Lu
    Feng, Weiyue
    Huang, Zhong-Xian
    Tan, Xiangshi
    AMINO ACIDS, 2011, 40 (04) : 1195 - 1204
  • [47] Comparison of In Vitro Metabolism of Ticlopidine by Human Cytochrome P450 2B6 and Rabbit Cytochrome P450 2B4
    Talakad, Jyothi C.
    Shah, Manish B.
    Walker, Gregory S.
    Xiang, Cathie
    Halpert, James R.
    Dalvie, Deepak
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (03) : 539 - 550
  • [48] Modeling of cytochrome P450 (Cyt P450, CYP) channels
    Jankowski, Christopher K.
    Chiasson, Julien B.
    Dako, Etienne
    Doucet, Kathy
    Surette, Marc E.
    Andre, Francois
    Delaforge, Marcel
    SPECTROSCOPY-BIOMEDICAL APPLICATIONS, 2011, 25 (02): : 63 - 87
  • [49] Thiomers: Inhibition of cytochrome P450 activity
    Iqbal, Javed
    Sakloetsakun, Duangkamon
    Bernkop-Schnuerch, Andreas
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2011, 78 (03) : 361 - 365
  • [50] Effect of kanglaite on rat cytochrome P450
    Du, Xiaoxiang
    Ye, Huizhou
    Zhang, Chunxia
    Ye, Lei
    Lin, Guanyang
    PHARMACEUTICAL BIOLOGY, 2015, 53 (07) : 995 - 1001